Healthcare & Pharmaceuticals

From patient care to innovation, we're supporting the future of healthcare.

Overview

About 10% of Australia's GDP is spent on health. What are we getting for that? We get more than just a trip to the doctor, that's for sure. Modern healthcare encompasses extraordinary technical advances, commercialisation, patents, trade marks and other IP, and a highly regulated pharmaceutical sector.

There's innovation too in the way health services are developed and delivered, from research and health precincts through to healthcare infrastructure such as hospitals or aged care homes which integrate the latest technology with old-fashioned care and compassion. For those running a healthcare facility, there are also medical negligence and disciplinary proceedings. Underlying it all is the need to protect, manage and utilise vast amounts of sensitive data within strict privacy laws. And then there are the business issues: corporate governance, real estate acquisition, planning approvals, investments, and exit strategies.

We might not be able to solve physical headaches as easily as you can, but we know how to deal with the legal headaches – and even stop them from happening.

Our team to support you

Toolkits

Insights
Fifty years of foreign investment regulation in Australia: The Foreign Acquisitions and Takeovers Act 1975, and what may come
28 Jul 2026 | Article
Read Insights
A new industrial court for Australia: what we know about the proposed Fair Work Court and its impact on employers
24 Jul 2026 | Article
Read Insights
Healthcare software: TGA clarifies when AI will be regulated as a medical device
24 Jul 2026 | Article
Read Insights
Legislating the Australian trade playbook: What the Trade and Investment Agreements (Consultation) Bill means for your business
16 Jul 2026 | Article
Read Insights
The Australia–India Annual Summit: from ECTA to CECA, and what it means for business
16 Jul 2026 | Article
Read Insights
Australia's Enhanced CIRMP Rules: what critical infrastructure operators need to know
23 Jun 2026 | Article
Read Insights
ASIC v Bekier: Ten D&O insurance and indemnity considerations
19 Jun 2026 | Article
Read Insights
ASIC v Bekier: Federal Court imposes $1.1 million in penalties and lengthy disqualification, and costs against former Star Entertainment CEO and General Counsel
17 Jun 2026 | Article
Read Insights
ASIC v Bekier: ASIC seeks millions in penalties and lengthy disqualification of former officers of Star Entertainment
3 Jun 2026 | Article
Read Insights
Annual Wage Review 2026: the immediate compliance impacts –and beyond
3 Jun 2026 | Article
Read Insights
Address psychosocial hazards in workplace investigations to protect your people and organisation
28 May 2026 | Article
Read Insights
Incoming changes to Australia's foreign investment framework: What investors need to know
20 May 2026 | Article
Read Insights